30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Fractyl Health Inc (GUTS)

Track

Over the last 90 days, Fractyl Health Inc. has seen significant insider buying activity, with a net value of $185,019.31. A total of 8 transactions were recorded, with 5 net buying insiders. Notably, the CEO, Harith Rajagopalan, made planned purchases. The stock has experienced a substantial 91.0% price increase over the same period.
Stock chart
Ticker: GUTS Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Royan Ajay
1 purchase — total 100,000 USD
Buy 12 Jun 2026
Value US$4,273,210.03 | Price 183.63 | Shares 56,409
Planned buy 10 Jun 2026
Value US$2,689,485.26 | Price 340.61 | Shares 778
Planned buy 10 Jun 2026
Value US$4,192,085.33 | Price 237.33 | Shares 73,487
Buy 10 Jun 2026
Value US$100,000.00 | Price 0.73 | Shares 1,000
Buy 10 Jun 2026
Value US$100,000.00 | Price 0.73 | Shares 1,000
Buy 10 Jun 2026
Value US$100,000.00 | Price 0.73 | Shares 1,000
Buy 10 Jun 2026
Value US$100,000.00 | Price 0.73 | Shares 1,000
Buy 8 Jun 2026
Value US$100,000.00 | Price 0.69 | Shares 1,000
Buy 4 Dec 2025
Value US$19,998.72 | Price 1.92 | Shares 10,416
Buy 14 Mar 2025
Value US$22,979.51 | Price 1.28 | Shares 17,901
Buy 14 Mar 2025
Value US$40,210.10 | Price 1.30 | Shares 31,000
Buy 13 Mar 2025
Value US$9,964.17 | Price 1.17 | Shares 8,550
Buy 13 Mar 2025
Value US$9,964.17 | Price 1.17 | Shares 8,550
Buy 13 Mar 2025
Value US$20,358.02 | Price 1.26 | Shares 16,129
Planned sale 31 Jan 2025
Value US$40,464.14 | Price 1.81 | Shares 22,346
Planned sale 31 Jan 2025
Value US$165,205.15 | Price 1.82 | Shares 90,972
Planned sale 30 Jan 2025
Value US$41,801.69 | Price 1.95 | Shares 21,472
Planned sale 30 Jan 2025
Value US$40,798.32 | Price 1.95 | Shares 20,948
Proposed sale 30 Jan 2025
Value US$226,078.40 | Price 2.02 | Shares 111,920
Proposed sale 30 Jan 2025
Value US$88,512.36 | Price 2.02 | Shares 43,818
Sale 11 Nov 2024
Value US$238,358.38 | Price 2.47 | Shares 96,517
Sale 11 Nov 2024
Value US$158,540.91 | Price 2.47 | Shares 64,197
Sale 12 Sep 2024
Value US$188,474.00 | Price 2.90 | Shares 65,000
Proposed sale 12 Sep 2024
Value US$185,212.76 | Price 2.85 | Shares 65,000
Buy 6 Feb 2024
Value US$6,999,990.00 | Price 15.00 | Shares 466,666
Buy 6 Feb 2024
Value US$4,999,995.00 | Price 15.00 | Shares 333,333
Buy 6 Feb 2024
Value US$4,999,995.00 | Price 15.00 | Shares 333,333
Buy 6 Feb 2024
Value US$4,999,995.00 | Price 15.00 | Shares 333,333
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-15 2026-06-12 B Purchase
2.3
Royan Ajay
Non-Executive Director
56,409 -29.9%
183.63
US$4,273,210 		56,409 -29.9% 183.63 US$4,273,210
2026-06-11 2026-06-10 PP Planned purchase
3.5
Rajagopalan Harith

Chief Executive Officer

Executive Director
778 +18.9%
340.61
US$2,689,485 		778 +18.9% 340.61 US$2,689,485
2026-06-11 2026-06-10 PP Planned purchase
3.5
Rajagopalan Harith

Chief Executive Officer

Executive Director
73,487 +37.4%
237.33
US$4,192,085 		73,487 +37.4% 237.33 US$4,192,085
2026-06-11 2026-06-10 B Purchase
Sheffield Ian
Non-Executive Director
1,000 +inf%
0.73
US$100,000 		1,000 +inf% 0.73 US$100,000
2026-06-11 2026-06-10 B Purchase
Sheffield Ian
Non-Executive Director
1,000 +inf%
0.73
US$100,000 		1,000 +inf% 0.73 US$100,000
2026-06-11 2026-06-10 B Purchase
2.3
BRADLEY WILLIAM
Non-Executive Director
1,000 +424.7%
0.73
US$100,000 		1,000 +424.7% 0.73 US$100,000
2026-06-11 2026-06-10 B Purchase
2.3
BRADLEY WILLIAM
Non-Executive Director
1,000 +424.7%
0.73
US$100,000 		1,000 +424.7% 0.73 US$100,000
2026-06-09 2026-06-08 B Purchase
Smith Weber Lara

Chief Financial Officer

Officer
1,000 +inf%
0.69
US$100,000 		1,000 +inf% 0.69 US$100,000
2025-12-08 2025-12-04 B Purchase
3.5
Rajagopalan Harith

Chief Executive Officer

Executive Director
10,416 +2.1%
1.92
US$19,999 		10,416 +2.1% 1.92 US$19,999
2025-03-18 2025-03-14 B Purchase
2.3
Royan Ajay
Non-Executive Director Large shareholder
17,901 +inf%
1.28
US$22,980 		17,901 +inf% 1.28 US$22,980
2025-03-18 2025-03-14 B Purchase
2.3
Barnes Kelly Ann
Non-Executive Director
31,000 +inf%
1.30
US$40,210 		31,000 +inf% 1.30 US$40,210
2025-03-17 2025-03-13 B Purchase
2.6
SCHULMAN AMY W
Non-Executive Director
8,550 +inf%
1.17
US$9,964 		8,550 +inf% 1.17 US$9,964
2025-03-17 2025-03-13 B Purchase
2.4
Conaway Samuel
Non-Executive Director
8,550 +inf%
1.17
US$9,964 		8,550 +inf% 1.17 US$9,964
2025-03-17 2025-03-13 B Purchase
2.3
BRADLEY WILLIAM
Non-Executive Director
16,129 +inf%
1.26
US$20,358 		16,129 +inf% 1.26 US$20,358
2025-02-03 2025-01-31 PlS Planned sale
3.7
Caplan Jay David

President, Chief Product Off.

Officer
22,346 -12.7%
1.81
US$40,464 		22,346 -12.7% 1.81 US$40,464
2025-02-03 2025-01-31 PlS Planned sale
3.5
Rajagopalan Harith

Chief Executive Officer

Executive Director
90,972 -15.6%
1.82
US$165,205 		90,972 -15.6% 1.82 US$165,205
2025-02-03 2025-01-30 PlS Planned sale
3.7
Caplan Jay David

President, Chief Product Off.

Officer
21,472 -12.3%
1.95
US$41,802 		21,472 -12.3% 1.95 US$41,802
2025-02-03 2025-01-30 PlS Planned sale
3.5
Rajagopalan Harith

Chief Executive Officer

Executive Director
20,948 -4.1%
1.95
US$40,798 		20,948 -4.1% 1.95 US$40,798
2025-01-30 2025-01-30 PrS Proposed sale
3.5
HARITH RAJAGOPALAN

Director; Officer

Executive Director
111,920
2.02
US$226,078 		111,920 2.02 US$226,078
2025-01-30 2025-01-30 PrS Proposed sale
3.7
JAY CAPLAN

Officer

Officer
43,818
2.02
US$88,512 		43,818 2.02 US$88,512
2024-11-13 2024-11-11 S Sale
3.5
Rajagopalan Harith

Chief Executive Officer

Executive Director
96,517 -16.4%
2.47
US$238,358 		96,517 -16.4% 2.47 US$238,358
2024-11-13 2024-11-11 S Sale
3.7
Caplan Jay David

President, Chief Product Off.

Officer
64,197 -29.5%
2.47
US$158,541 		64,197 -29.5% 2.47 US$158,541
2024-09-13 2024-09-12 S Sale
3.7
Caplan Jay David

President, Chief Product Off.

Officer
65,000 -68.1%
2.90
US$188,474 		65,000 -68.1% 2.90 US$188,474
2024-09-12 2024-09-12 PrS Proposed sale
3.7
JAY D CAPLAN

Officer

Officer
65,000
2.85
US$185,213 		65,000 2.85 US$185,213
2024-02-08 2024-02-06 B Purchase
0.9
Elia Marc
Non-Executive Director
466,666 +33.6%
15.00
US$6,999,990 		466,666 +33.6% 15.00 US$6,999,990
2024-02-08 2024-02-06 B Purchase
Mithril LP
Large shareholder
333,333 +36.3%
15.00
US$4,999,995 		333,333 +36.3% 15.00 US$4,999,995
2024-02-08 2024-02-06 B Purchase
2.3
Royan Ajay
Non-Executive Director Large shareholder
333,333 +36.3%
15.00
US$4,999,995 		333,333 +36.3% 15.00 US$4,999,995
2024-02-06 2024-02-06 B Purchase
CVF, LLC

(4)

Large shareholder
333,333 +7.7%
15.00
US$4,999,995 		333,333 +7.7% 15.00 US$4,999,995
Explore more

More insider trading research around Fractyl Health Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America